SEREX
2015-01-13azim58 - SEREX
SEREX = Serological Analysis of Recombinant cDNA (Complementary
Deoxyribonucleic Acid) Expression Libraries
SEREX first developed in 1995
see
Human neoplasms elicit multiple specific immune responses in the
autologous host. paper
SEREX paper
performance of protein microarrays using SEREX derived antigens paper
SEREX review papers
Identification of human tumor antigens by serological expression cloning
c an online review on SEREX
The reverse proteomics for identification of tumor antigens.
Pusan National University in Busan Korea 2007
This article can't be found (the links to it are to the wrong article)
Potential target antigens for immunotherapy identified by serological
expression cloning (SEREX).
Dirk Jager 2007 Germany
Identification of tumor antigens as potential target antigens for
immunotherapy by serological expression cloning.
Cancer Immunology, Immunotherapy 2003 Greece
===========================================================================
Serum autoantibodies as biomarkers for early cancer detection. paper
===========================================================================
High throughput proteomic strategies for identifying tumour-associated
antigens. paper
===========================================================================
Identification of tumour antigens by serological analysis of cDNA
expression cloning. paper
===========================================================================
Mapping the high throughput SEREX technology screening for novel tumor
antigens.
Combinatorial Chemistry & High Throughput Screening. 2012 from Chengdu
Sichuan China
This article is behind a paywall
===========================================================================
Identifying autoantibody signatures in cancer: a promising challenge.
Desmetz C, Maudelonde T, Mangé A, Solassol J.
Expert Rev Proteomics. 2009 Aug;6(4):377-86. doi: 10.1586/epr.09.56.
Review.
CHU Montpellier, Laboratoire de Biologie Cellulaire et Hormonale,
Hôpital Arnaud de Villeneuve, 371 Avenue du Doyen Giraud, Montpellier,
F-34295, France.
article is behind a paywall
===========================================================================
This article looks quite good and interesting and has some nice figures.
The current status of cancer biomarker research using
tumour-associated antigens for minimal invasive and early
cancer diagnostics
http://www.sciencedirect
.com/science/article/pii/S1874391912005520
or
"C:\kurt\storage\CIM Research Folder\DR\2013\2-18-13\SEREX paper\The
current status of cancer biomarker research using tumour-associated
antigens for minimal invasive and early cancer diagnostics.pdf"